Trial Profile
The Role of 3-Deoxy-3[18]Fluorothymidine Positron Emission Tomography (FLT-PET) in Proliferation of Colorectal Liver Metastases
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 09 Feb 2022
Price :
$35
*
At a glance
- Drugs F-18 fluorothymidine (Primary)
- Indications Cancer metastases
- Focus Diagnostic use
- Acronyms FLT-PET
- 26 May 2014 New trial record